Dec. 16, 2025 OR Royalties Inc. is pleased to provide the following select asset updates. Amounts presented are in United States dollars, except where otherwise noted. Jason Attew, President & CEO of ...

Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection. Intercept’s CEO ...

Ripples maintain time-locked occurrence across the septo-temporal axis and hemispheres while showing local phase coupling, revealing a dual mode of synchrony in CA1 network dynamics.

Westgold Resources Limited (ASX: WGX) (TSX: WGX) (Westgold or the Company) is pleased to announce it has entered into a ...

Origen Resources Inc. is pleased to announce results from the recently completed LiDAR and rock sampling programs on its 100%-owned, road accessible Broken Handle and Bonanza projects located north of ...